Abmtx Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $30M

  • Investors
  • 13

Abmtx General Information

Description

Developer of small-molecule therapeutics designed to treat cancer and brain metastases. The company utilizes a proprietary brain-penetrant kinase drug discovery platform to develop small molecules with high water solubility and blood-brain barrier penetration, enabling oncology patients to access targeted therapies for primary brain cancers and metastatic diseases.

Contact Information

Website
www.abmtx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 403-A19, 4th Floor, Building 1
  • Number 298 Xiangke Road, China (China) Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 136
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 403-A19, 4th Floor, Building 1
  • Number 298 Xiangke Road, China (China) Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 136

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abmtx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 04-Jan-2022 $30M Completed Generating Revenue
3. Later Stage VC (Series A1) 07-Aug-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Jan-2019 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Abmtx’s complete valuation and funding history, request access »

Abmtx Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Baidu Ventures Corporate Venture Capital Minority
Delta Capital Venture Capital Minority
Hermed Capital Venture Capital Minority
Highlight Capital Venture Capital Minority
Photon Fund Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Abmtx FAQs

  • When was Abmtx founded?

    Abmtx was founded in 2015.

  • Where is Abmtx headquartered?

    Abmtx is headquartered in Shanghai, China.

  • What industry is Abmtx in?

    Abmtx’s primary industry is Drug Discovery.

  • Is Abmtx a private or public company?

    Abmtx is a Private company.

  • What is Abmtx’s current revenue?

    The current revenue for Abmtx is .

  • How much funding has Abmtx raised over time?

    Abmtx has raised $50M.

  • Who are Abmtx’s investors?

    Baidu Ventures, Delta Capital, Hermed Capital, Highlight Capital, and Photon Fund are 5 of 13 investors who have invested in Abmtx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process